Long-term expansion of effector/memory V{delta}2- {gamma}-{delta} T cells is a specific blood signature of CMV infection

Blood

Volumn 112, Issue 4, 2008, Pages 1317-1324

  Pitard, Vincent ^a,b   Roumanes, David ^a,b   Lafarge, Xavier ^a,b   Couzi, Lionel ^a,b,c   Garrigue, Isabelle ^a,d   Lafon, Marie Edith ^a,d   Merville, Pierre ^a,b,c   Moreau, Jean François ^a,b,d   Déchanet Merville, Julie ^a,b,e  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS   (France)

^c Departement de Néphrologie et Transplantation Rénale   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e CNRS Bordeaux Segalen University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CELL EXPANSION; CELL POPULATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; FEMALE; FIBROBLAST; GAMMA DELTA T CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; V DELTA 2 T CELL; BLOOD; CELL CULTURE; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOTOXICITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE COUNT; VIROLOGY;

LYMPHOCYTE ANTIGEN RECEPTOR;

CELL PROLIFERATION; CELLS, CULTURED; CYTOMEGALOVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 51649100338     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-01-136713     Document Type: Article

References (43)

1. Cobbold M, Khan N, Pourgheysari B, et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med. 2005;202: 379-386.
2. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T-cell clones. Science. 1992;257:238-241.
3. Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ Tcells in protection against CMV disease. Blood. 2003;101: 2686-2692.
4. Gerna G, Lilleri D, Fornara C, et al. Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation. Am J Transplant. 2006;6:2356-2364.
5. Dechanet J, Merville P, Lim A, et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest. 1999; 103:1437-1449.
6. Halary F, Pitard V, Dlubek D, et al. Shared reactivity of Vδ2(neg)γ δ T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J Exp Med. 2005;201:1567-1578.
7. Thedrez A, Sabourin C, Gertner J, et al. Self/non-self discrimination by human gamma/delta T cells: simple solutions for a complex issue? Immunol Rev. 2007;215:123-135.
8. Pennington DJ, Vermijlen D, Wise EL, Clarke SL Tigelaar RE, HaydayAC. The integration of conventional and unconventional T cells that characterizes cell-mediated responses. Adv Immunol. 2005;87:27-59.
9. Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol. 2002;2:336-345.
10. Poccia F, Agrati C, Martini F, Capobianchi MR, Wallace M, Malkovsky M. Antiviral reactivities of gammadeltaT cells. Microbes Infect. 2005;7:518-528.
11. Bonneville M, Fournie JJ. Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites. Microbes Infect. 2005;7:503-509.
12. Morita CT, Jin C, Sarikonda G, Wang H. Nonpep-tide antigens, presentation mechanisms, and im-munological memory of human Vg9Vd2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev. 2007;215:59-76.
13. Beldjord K, Beldjord C, MacIntyre E, Even J, Sigaux F. Peripheral selection of Vd1 + cells with restricted T cell receptor d gene junctional repertoire in the peripheral blood of healthy donors. J Exp Med. 1993;178:121-127.
14. Boullier S, Cochet M, Poccia F, Gougeon M-L. CDR3-independent gamma/delta Vd1 + T-cell expansion in the peripheral blood of HIV-infected persons. J Immunol. 1995;154:1418-1431.
15. Hviid L, Akanmori BD, Loizon S, et al. High frequency of circulating gamma delta T cells with dominance of the v(delta)1 subset in a healthy population. Int Immunol. 2000;12:797-805.
16. Spada F, Grant E, Peters P, et al. Self-recognition of CD1 by gamma/deltaT cells: implications for innate immunity. J Exp Med. 1999;191:937-948.
17. Wu J, Groh V, Spies T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma deltaT cells. J Immunol. 2002;169:1236-1240.
18. 2+ T cells during my-cobacterial infections. Science. 2002;295:2255-2258.
19. Sicard H, Ingoure S, Luciani B, et al. In vivo im-munomanipulation of V gamma 9V delta 2 Tcells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J Immunol. 2005;175:5471-5480.
20. Hoft DF, Brown RM, Roodman ST. Bacille Calmette-Guerin vaccination enhances human gamma delta Tcell responsiveness to mycobac-teria suggestive of a memory-like phenotype. J Immunol. 1998;161:1045-1054.
21. Dieli F, Sireci G, Di Sano C, et al. Ligand-specific alphabeta and gammadelta T-cell responses in childhood tuberculosis. J Infect Dis. 2000;181:294-301.
22. Lafarge X, Merville P, Cazin MC, et al. Cytomega-lovirus infection in transplant recipients resolves when circulating gammadeltaT lymphocytes expand, suggesting a protective antiviral role. J Infect Dis. 2001;184:533-541.
23. Ehl S, Schwarz K, Enders A, et al. Avariant of SCID with specific immune responses and predominance of gammadeltaT cells. J Clin Invest. 2005;115:3140-3148.
24. de Villartay JP, Lim A, Al-Mousa H, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115:3291-3299.
25. Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for de-granulation. J Immunol Methods. 2003;281:65-78.
26. Déchanet J, Merville P, Berge F, et al. Major expansion of gamma/delta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis. 1999;179:1-8.
27. Wang EC, Moss PAH, Frodsham P, Lehner PJ, Bell JI, Borysiewicz LK. CD8highCD57+ T lymphocytes in normal, healthy individuals are oligo-clonal and respond to human cytomegalovirus. J Immunol. 1995;155:5046-5056.
28. Parker CM, Groh V, Band H, et al. Evidence for extrathymic changes in the Tcell receptor gamma/delta repertoire. J Exp Med. 1990;171:1597-1612.
29. David-Ameline J, Lim A, Davodeau F, et al. Selection of T cells reactive against autologous B lym-phoblastoid cells during chronic rheumatoid arthritis. J Immunol. 1996;157:4697-4706.
30. Angelini DF, Borsellino G, Poupot M, et al. FcγRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways. Blood. 2004;104:1801-1807.
31. Brandes M, Willimann K, Lang AB, et al. Flexible migration program regulates gamma delta T-cell involvement in humoral immunity. Blood. 2003;102:3693-3701.
32. 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J Immunol. 2002;168:1484-1489.
33. Labalette M, Queyrel V, Masy E, Noel C, Pruvot FR, Dessaint JP. Implication of cyclosporine in up-regulation of Bcl-2 expression and maintenance of CD8 lymphocytosis in cytomegalovirus-infected allograft recipients. Transplantation. 1995;59:1714-1722.
34. Sylwester AW, Mitchell BL, Edgar JB, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med. 2005;202:673-685.
35. Khan N, Hislop A, Gudgeon N, et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomeg-alovirus impairs the response to a coresident EBV infection. J Immunol. 2004;173:7481-7489.
36. Khan N, Shariff N, Cobbold M, et al. Cytomegalo-virus seropositivity drives the CD8 T-cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169:1984-1992.
37. Plachter B, Sinzger C, Jahn G. Cell types involved in replication and distribution of human cytomegalovirus. Adv Virus Res. 1996;46:195-260.
38. Amyes E, Hatton C, Montamat-Sicotte D, et al. Characterization of the CD4+ T-cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med. 2003;198:903-911.
39. Khan N, Cobbold M, Keenan R, Moss PA. Comparative analysis of CD8+ T-cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J Infect Dis. 2002;185:1025-1034.
40. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379-385.
41. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001;291:2413-2417.
42. Dieli F, Poccia F, Lipp M, et al. Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med. 2003;198:391-397.
43. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 2003;3:199-210.